Clinical trials
Merosin Deficient CMD (Full or Partial) clinical trials
Below are recruiting merosin deficient cmd (full or partial) clinical trials, each written for real people, not researchers. We’re tracking 236 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07234409Recruiting
Robotic partial nephrectomy for small kidney tumors
This trial compares different surgical methods for removing kidney tumors using a single-port robot. It aims to find the best approach for treating stage 1 kidney cancer.
MilanAges 18 years+ - NCT07228195RecruitingPhase 4
Study on SGLT2i therapy after islet transplantation
This trial tests whether a diabetes medication called empagliflozin (an SGLT2 inhibitor) can help people who have had an islet transplant (TPIAT) better manage their blood sugar. It aims to see if it improves how well the transplanted islets work.
Minneapolis, MinnesotaAges 18–70 - NCT04927819Recruiting
Extra-short versus standard dental implants in a fixed bridge
This study compares extra-short dental implants versus standard-length implants when they are joined together in the same fixed bridge. It may help people understand which implant type works better for supporting a stable multi-tooth replacement.
Vitoria-GasteizAges 18 years+ - NCT06751498Recruiting
Predicting kidney function after partial nephrectomy with AI
This trial uses a special computer model to predict how well your kidneys will work after surgery to remove part of a kidney (partial nephrectomy). It may help doctors plan better care for people with early-stage kidney tumors.
Nanjing, JiangsuAges 18–80 - NCT06936046RecruitingPhase 2
Enhanced treatment for newly diagnosed GBM with partial resection or early progression
This trial tests a stronger combination of treatments given after surgery for people with glioblastoma (GBM) that was only partially removed or that starts growing again quickly. It aims to see if this approach can help control the tumor better. You may be eligible if you are newly diagnosed, over 18, have good organ function, and do not have other serious health issues.
HangzhouAges 18 years+ - NCT07179276Recruiting
Testing CO₂ gap to guide septic shock treatment
This trial checks if measuring the carbon dioxide gap (a sign of how well blood is flowing to organs) can help doctors improve treatment for people in septic shock. Septic shock is a severe infection that causes very low blood pressure and organ damage.
AngersAges 18 years+ - NCT07141225Recruiting
Testing no-clamp, no-suture robot kidney surgery
This study is testing a special technique in robot-assisted kidney surgery where the blood supply to the kidney is not clamped and the tumor is removed without sutures. It may reduce damage to healthy kidney tissue and speed recovery.
Nanjing, JiangsuAges 18–80 - NCT07134777Recruiting
Visual Training After Stroke: Restoring Sight
This study uses visual training exercises you can do at home on your computer to try to restore some vision lost after a stroke. It also involves a few days of testing and brain scans (MRI) at our lab to see how the training works.
Rochester, New YorkAges 21–80 - NCT04276246Recruiting
Dental implant supports for removable dentures in back-tooth gaps
This trial tests whether small “supporting” implants can help hold a removable partial denture more securely. It’s for adults missing back teeth on both sides (a specific dental gap pattern) and may improve comfort and fit.
BaselAges 18 years+ - NCT07124520Recruiting
Lingual strength training after tongue cancer surgery
This study tests if using a device to exercise your tongue after partial tongue removal helps you recover tongue strength and function better than standard care. It is for people having their first surgery for oral tongue cancer.
Basking Ridge, New JerseyAges 18 years+ - NCT07107581Enrolling by invitation
Exactech knee replacement follow-up study
This study is following patients who have or will receive an Exactech total knee replacement. It looks at how well the knee works over time and helps doctors understand long-term results.
DeLand, FloridaAges 18 years+ - NCT06967012RecruitingPhase 4
Zonisamide as add-on treatment for children with epilepsy
This trial tests adding zonisamide to the current epilepsy medication for children aged 1 to 14 who still have focal seizures. The goal is to see if the combination works better and is safe.
Nantong, JiangsuAges 1–14 - NCT07062614Recruiting
Hair test for HIV treatment adherence
This study uses hair samples to see if they can tell if someone is taking their HIV medication regularly. If you've been on a stable HIV pill regimen for at least 6 months, this study may help improve monitoring for other patients.
ToulouseAges 18–70 - NCT06563726Recruiting
Sodium awareness study for breastfeeding moms of preemies
This study looks at whether tracking sodium levels in breast milk can help mothers of preterm babies improve their milk supply. If you are a new mom who gave birth before 35 weeks and plan to pump for at least two weeks, this trial may help you learn more about your milk.
Seattle, WashingtonAges Any age - NCT07025408RecruitingPhase 2
Testing a new burn treatment for second-degree burns
This trial tests a new medicine called KJ101 for healing deep second-degree burns. It may help close the wound faster and reduce scarring.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06995664Recruiting
Higher radiation dose for kidney cancer that has spread
This trial tests whether giving a higher radiation dose to some tumors can help control kidney cancer that has spread to other parts of the body. It is for people who cannot have surgery to remove these tumors and are already receiving other treatments.
LondonAges 18 years+ - NCT07020169Recruiting
Using AI 3D kidney models to guide partial nephrectomy
This trial tests if a 3D kidney model made with artificial intelligence helps surgeons remove a kidney tumor (partial nephrectomy) more precisely. It may help preserve healthy kidney tissue while treating the cancer.
Nanjing, JiangsuAges 18–80 - NCT07019857Recruiting
Thymus removal and immunity in infant heart surgery
This study looks at how removing the thymus gland during infant heart surgery affects the immune system. It compares babies who have their thymus removed with those who have heart surgery without removing it, and with babies having other types of surgery.
NantesAges Up to 6 months - NCT07006012Recruiting
Study of RGL-305 for lymphoma with minimal residual disease
This trial tests if a new treatment called RGL-305 can help people with lymphoma who still have tiny amounts of cancer cells left after previous treatment. It is for those whose disease has responded to prior therapy but is not completely gone at the genetic level.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07006662Recruiting
Mapping chest wall blood vessels for partial breast reconstruction
This study tests a new way to find important blood vessels in the chest wall using ultrasound before breast surgery. If successful, it could help surgeons plan partial breast reconstruction more precisely.
Stoke-on-TrentAges 18 years+ - NCT06954116RecruitingPhase 2
Iparomlimab and Tuvonralimab before surgery for liver cancer
This trial tests two drugs given before surgery to people with liver cancer that has a high chance of coming back. The goal is to see if the drugs can shrink the tumor and lower the risk of recurrence.
Wuhan, HubeiAges 18–75 - NCT06946238Recruiting
Single-dose radiation after surgery for low-risk breast cancer
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
MilanAges 40 years+ - NCT06943469Recruiting
Study of special formula for babies with allergy risk
This study tests a special baby formula (partially broken-down protein with added prebiotics and probiotics) to see if it helps strengthen babies' skin barrier and reduce allergy risk. It's designed for newborns who have a family history of allergies.
BrugesAges 1 day–2 weeks - NCT06945640Enrolling by invitation
Testing a 3D imaging system for robot kidney surgery
This study tests a new 3D imaging system (RUS NE) to help surgeons perform robot-assisted partial nephrectomy more safely and effectively. If you have a small to medium-sized kidney tumor and are already scheduled for this surgery, the researchers want to compare your outcomes to people who had the standard procedure.
SeoulAges 20–80
Hear when a new Merosin Deficient CMD (Full or Partial) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for merosin deficient cmd (full or partial)?
- Yes. Clin2 currently lists 236 recruiting merosin deficient cmd (full or partial) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a merosin deficient cmd (full or partial) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a merosin deficient cmd (full or partial) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.